Trials / Completed
CompletedNCT02255136
Efficacy Study of Homeopathic Medicines in Treatment of Allergic Rhinitis and/or Induced Bronchial Asthma
An Evidence-based Single-blind Randomized Controlled Trial Searching for the Efficacy of Homoeopathic Medicines in Reducing Serum Levels of Cytokines (IL - 10, 13) and Immunoglobulin E in Allergic Rhinitis and/or Induced Bronchial Asthma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Mahesh Bhattacharyya Homoeopathic Medical College and Hospital · Other Government
- Sex
- All
- Age
- 5 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test whether individualized homeopathic medicines can produce any significant effect beyond placebo in treatment of allergic rhinitis and/or induced bronchial asthma
Detailed description
A prospective, single-blind (subject), randomized, placebo-controlled, parallel group, interventional clinical trial is being conducted on 100 participants (subjects 50, control 50) suffering from allergic rhinitis and/or induced bronchial asthma since March 1, 2012 at Mahesh Bhattacharyya Homeopathic Medical College and Hospital, Government of West Bengal. This trial is aimed at exploring the efficacy of homeopathic medicines in comparison with placebo in reducing serum interleukin 10, 13 and immunoglobulin E measured at timeline of 1 year of treatment and absolute eosinophil count every 4 months up to 1 year. Matching for independent and consequent variables will be done to test for bias. Parametric or non-parametric tests will be employed as per distribution of data at the end of the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Individualized homeopathic medicines | 5 ml dose of indicated individualized homeopathic medicine in centesimal or 50 millesimal potencies as appropriate; twice daily for 1 year |
| OTHER | Placebo | Placebo, in the form of a single drop of rectified spirit in 5 ml of distilled water |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-10-02
- Last updated
- 2018-08-16
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02255136. Inclusion in this directory is not an endorsement.